
Shannon Lantzy, PhD on Accelerating Innovation in AID and Why Diabetes Tech Cannot Ship Like Angry Birds
An interview with Shannon Lantzy, PhD about why diabetes technology should be judged by how many “spoons” it gives back, not only by A1C and time in range. We dig into FDA decision-making, cybersecurity, faster software













